A summary of the inspection report of Semler Research Center where bioequivalence studies were performed.
Regulates clinical trials and market authorizations in India
An online public record system for registration of clinical trials being conducted in India.
Agoura Hills, California, United States, Tuesday, October 01, 2013 -- (Business Wire India)
Semler Research Centre Pvt. Ltd. (SRC), a leading Contract Research Organization based in Bengaluru, India entered into an agreement with Excel Dwellings (EDI) for development of products. EDI will fund intially USD 5 Million which will be utilised for product development opportunities. EDI will work closely with SRC for development of products in regulated markets through an exclusive manufacturing and distribution partner.
A privately owned pharmaceutical services company offering best-in-class pharmaceutical, clinical, regulatory & capital solutions across geographies. Our unique delivery model helps clients optimize their resources while saving on time & costs. Our R&D centers are in compliance with GLP, GCP and other regulatory guidelines.
INDIA Tel: +91 80 4262 7200
US Tel:+1 818 760 1000